UPDATED Aug 16, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRVI | US$2.61 | 0.4% | -73.0% | US$664.7m | US$4.13 | PS1.7x | E60.8% | n/a | ||
SRZN | US$11.14 | 2.7% | 47.5% | US$95.5m | US$37.00 | PS7.6x | E-36.2% | n/a | ||
ZBIO | US$16.82 | 0.4% | n/a | US$708.3m | US$31.57 | PS47.2x | E5.1% | n/a | ||
ANEB | US$2.50 | 2.5% | 26.3% | US$102.7m | n/a | PB7.6x | E-22.3% | n/a | ||
INVA | US$20.92 | 0.2% | 13.9% | US$1.3b | US$41.00 | PE34.1x | E32.2% | 0% | ||
IFRX | US$0.86 | 4.3% | -37.5% | US$58.5m | US$3.83 | PS306.8x | E-9.4% | n/a | ||
KROS | US$14.48 | 0.4% | -68.2% | US$588.1m | US$23.00 | PE31.3x | E-36.0% | n/a | ||
BMEA | US$1.73 | 2.4% | -70.1% | US$102.9m | US$7.67 | PB3.7x | E-6.0% | n/a | ||
IMMX | US$2.27 | 3.7% | 19.5% | US$65.5m | US$7.00 | PB14.1x | E-16.4% | n/a | ||
SXTC | US$1.60 | 1.3% | -80.4% | US$185.6m | n/a | PS106.6x | n/a | n/a | ||
FATE | US$1.09 | 1.9% | -67.9% | US$125.7m | US$5.45 | PS14.8x | E-4.5% | n/a | ||
INMB | US$2.53 | 3.3% | -64.5% | US$67.3m | US$5.25 | PS1345.2x | E23.7% | n/a | ||
CPIX | US$3.13 | 4.7% | 123.6% | US$46.8m | n/a | PS1.1x | n/a | n/a | ||
RCKT | US$3.05 | 0.7% | -83.9% | US$329.1m | US$7.43 | PB0.9x | E14.5% | n/a | ||
XNCR | US$7.68 | 0.4% | -52.7% | US$547.8m | US$26.90 | PS3.7x | E18.5% | n/a | ||
CRIS | US$1.83 | 8.9% | -56.2% | US$22.9m | US$16.33 | PS2x | E16.5% | n/a | ||
ITRM | US$0.86 | 5.3% | -32.6% | US$38.5m | US$7.00 | PE-1.6x | E74.8% | n/a | ||
TVRD | US$24.00 | 0.9% | n/a | US$225.1m | US$56.43 | PB6.8x | E-48.5% | n/a | ||
MIST | US$1.70 | 1.2% | 26.9% | US$166.4m | US$3.33 | PE-3x | E15.3% | n/a | ||
ADVM | US$2.86 | 3.2% | -58.1% | US$60.0m | US$19.50 | PS60x | E-1.0% | n/a | ||
ESLA | US$0.91 | 5.8% | -35.5% | US$33.7m | US$16.00 | PE-2.8x | E56.7% | n/a | ||
HBIO | US$0.53 | 8.1% | -82.1% | US$23.6m | US$3.00 | PB1.5x | E96.7% | n/a | ||
ELDN | US$2.63 | 1.2% | -3.7% | US$157.5m | US$9.50 | PE10.8x | E-28.9% | n/a | ||
KALA | US$8.32 | 3.1% | 36.2% | US$58.4m | US$13.00 | PE-1.6x | E-0.6% | n/a |